169324 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Intracellular protein regulatory factors and their receptors, e.g. including ion channels
BRIGHTFIELD TRIPLEX IMMUNOHISTOCHEMISTRY ASSAY FOR EVALUATING THE COLOCALIZATION OF THE ER, PR, AND KI-67 BIOMARKERS IN CELLS
#2DETECTING CANCER
#3DUAL SPECIFICITY ANTIBODIES TO HUMAN PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR
#4GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS
#5Methods for Diagnosing and Treating Vestibular Schwannoma
#6PROTEIN BIOMARKERS FOR USE IN LUPUS NEPHRITIS
#7CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#8ANTI-TLR9 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#9DETECTING CANCER
#10COVALENT TETHERING OF PORTAL PROTEIN INTO SOLID-STATE NANOPORES
#11RECOMBINANT FUSION POLYPEPTIDES FOR SECRETING SOLUBLE, HETEROLOGOUS CARGO
#12BIOMARKER PANEL, MICROFLUIDIC DEVICE AND DETECTION KIT FOR CAPTURING CIRCULATING TUMOR CELLS
#13METHODS FOR DETECTING FRACTURE-RELATED INFECTION (FRI)
#14BIOMARKERS FOR DETECTING AND/OR DETERMINING A TREATMENT REGIMEN FOR ALZHEIMER'S DISEASE
#15COMPOSITIONS AND METHODS FOR SCREENING AND IDENTIFYING IMMUNE MODULATORS
#16INDUCIBLE SYSTEMS FOR ALTERING GENE EXPRESSION IN HYPOIMMUNOGENIC CELLS
#17MODIFICATION OF VOLTAGE-GATED CHANNELS IN NEURONS WITH FLUORESCENT DONOR-ACCEPTOR PAIRS
#18METHOD OF BREAST CANCER BIOMARKER DETECTION USING A BIOSENSOR BASED ON A FIBER-OPTIC BALL RESONATOR
#19CONSTRUCTION METHOD OF BENIGN-MALIGNANT PULMONARY NODULE DIFFERENTIAL DIAGNOSIS MODEL BASED ON SINGLE-CELL IMMUNE ATLAS
#20PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#21DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#22COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#23PROLIFERATION ASSAY FOR FIXED SOLID TUMORS
#24MODIFIED ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF
#25ANTIGEN BINDING CONSTRUCTS TO CD8
#26BIOMARKERS FOR ENDOMETRIAL CANCER
#27REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN
#28Anti-mGluR2 Biparatopic Nanobodies and Uses Thereof
#29APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS
#30Assessment of immune cells in the uterine fluid at the time of the embryo transfer
#31TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR
#32BIOMARKERS OF LYSOSOMAL STORAGE DISEASE
#33COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#34METHOD FOR ANALYZING G-PROTEIN CONJUGATED RECEPTOR
#35ANTI-CD7 NANOBODY, AND DERIVATIVE THEREOF AND USE THEREOF IN TUMOR THERAPY
#36NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS
#37T Cell Receptor Identification
#38COMPOSITIONS FOR USE WITH MULTIPLE FLUOROPHORES AND METHODS OF USING
#39IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#40COMBINATION THERAPY FOR TREATMENT OF CANCER COMPRISING ANTI-PD-L1 AND ANTI-CD73 ANTIBODIES
#41TREATING TUBEROUS SCLEROSIS COMPLEX-ASSOCIATED DISEASES
#42CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM CELLS (LSCS)
#43METHODS FOR TREATING NOTCH1-DRIVEN CANCERS
#44T CELL RECEPTOR MULTIMERS AND USES THEREOF
#45CHROMOGENIC MULTIPLEXING METHODS AND SYSTEMS FOR IDENTIFYING A CANCER OF UNKNOWN PRIMARY ORIGIN
#46BRUCELLOSIS CELL IMMUNE PROTEIN AND USE THEREOF
#47METHODS OF TREATING IMMUNOTHERAPY-ASSOCIATED ADVERSE EFFECTS
#48METHOD FOR IDENTIFYING ASTROCYTE POPULATION HAVING NERVE-SUPPORTING FUNCTION OR ENHANCED THE FUNCTION
#49ANGIOGENESIS INHIBITING PEPTIDE AND USE THEREOF
#50MODULAR BIOSENSOR FOR RECEPTOR TYROSINE KINASE ACTIVITY
#51INHIBITORS OF COMPLEMENT FACTOR H
#52METHODS FOR DIAGNOSING OR TREATING HEALTH CONDITIONS OR OPTIMIZING THERAPEUTIC EFFICACY OF CAR-T CELLS THERAPIES
#53CLINICAL TIER GRADING FOR PROGNOSIS OF IMMUNE CHECKPOINT INHIBITOR EFFICACY AND CLINICAL STATUS
#54SUPPORT, LIGAND-BONDED SUPPORT, AFFINITY PARTICLE, REAGENT AND KIT INCLUDING THE SAME, AND DETECTION METHOD
#55SIMMPYRAs: Novel Drugs for Triple Negative Breast Cancer
#56ANTIBODY OR ANTIGEN-BINDING FRAGMENT CAPABLE OF IDENTIFYING ANG-2, AND BISPECIFIC ANTIBODY FOR SIMULTANEOUSLY IDENTIFYING VEGF AND ANG-2
#57COMBINATION OF A GREMLIN-1 ANTAGONIST WITH A CYTIDINE ANALOGUE OR DEOXYCYTIDINE ANALOGUE
#58BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF
#59METHODS FOR THE DIAGNOSIS AND TREATMENT OF T-CELL MALIGNANCIES
#60OLFACTORY RECEPTOR GENE FOR DIAGNOSING SKIN AGING AND USE THEREOF
#61ANTI-CD39 NANOBODY AND USES THEREOF
#62METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#63Human Epidermal Growth Factor Receptor Binding Molecule and Use Thereof
#64CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#65Diagnosis of Congenital Heart Block
#66MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#67CD161 BINDING PROTEINS AND RELATED METHODS
#68HIGH RISK BIOMARKERS FOR MYELOMA PRECURSOR DISEASE PROGRESSION AND METHODS OF USE THEREOF
#69ANTI-CD160 TRANSMEMBRANE ISOFORM ANTIBODIES
#70SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS
#71Mutant Human Nax Proteins and Screening Methods
#72MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS
#73Bone Marrow Adipose Portion Isolation Methods
#74ANTIBODY, IMMOBILIZED ANTIBODY USING THE SAME, ANTIBODY COMPOSITION, REAGENT FOR IMMUNOASSAY AND IMMUNOASSAY METHOD, AS WELL AS METHOD FOR IMPROVING REACTIVITY OF ANTIBODY WITH ANTIGEN
#75NUCLEIC ACID LINKED IMMUNE-SANDWICH ASSAY (NULISA)
#76ANTI-UBIQUITIN SYNTHETIC ANTIBODY
#77DIAGNOSTIC METHODS FOR CANCER USING EPHRINB2 EXPRESSION
#78METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
#79A BIOMARKER INDICATING THE THERAPEUTIC EFFICACY OF EXTRACELLULAR VESICLE (EV)- PREPARATIONS
#80METHODS FOR PREDICTION AND MONITORING OF SPONTANEOUS PRETERM BIRTH
#81METHODS TO DETERMINE CD4+ MEMORY T CELL RESPONSES TO SARS-COV-2 INFECTION OR VACCINATION
#82METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#83METAMATERIAL SENSING PLATFORM BASED ON NANODISK STRUCTURE
#84BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSTIC TEST
#85Methods for Sample Quality Assessment
#86IMPROVED EXOSOME PROFILING FOR THERAPY AND DIAGNOSIS
#87Aptamer-Based Fluorescence Polarization Detection Method for Extracellular Vesicles and Its Application
#88LYMPHANGIOGENESIS-PROMOTING AGENTS
#89ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE
#90DUAL SPECIFICITY ANTIBODIES TO HUMAN PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR
#91CD28 BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF
#92STEAP2 ANTIBODY DRUG CONJUGATES AND USES THEREOF
#93METHODS FOR PREDICTING RESPONSE TO AN IMMUNOTHERAPEUTIC TREATMENT IN A PATIENT WITH A CANCER
#94ETHYLENE RECEPTORS AND BINDING DOMAINS WITH MODIFIED BINDING KINETICS FOR ETHYLENE
#95COVID-19 THERANOSTIC
#96Isolation and Diagnostics of Fetal Cells
#97METHOD TO INVESTIGATE FUNCTION OF VOLTAGE-GATED SODIUM CHANNELS IN CELLS
#98ANTIBODY SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, FUSION PROTEIN CONTAINING THE SAME, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF
#99SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF
#100Tissue-Specific Extracellular Vesicle Isolation and Validation
#101K17 AS A BIOMARKER FOR TUMOR RESPONSE TO IMMUNOTHERAPY
#102URINARY BIOMARKERS FOR ACTIVE LUPUS NEPHRITIS AND METHODS OF USE THEREOF
#103GENETICALLY ENCODED VOLTAGE INDICATORS AND USES THEREOF
#104ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF
#105PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF
#106NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS
#107Inhibitors of complement factor H
#108ARRAYS TARGETING DIFFERENTIALLY ACCESSIBLE CHROMATIN REGIONS USING QUANTITATIVE POLYMERASE CHAIN REACTION
#109ANTIGEN REACTIVE T-CELL RECEPTORS
#110METHODS FOR PREDICTING MULTI-ORGAN METASTATIC DISEASE AND OVERALL AND PROGRESSION FREE SURVIVAL IN SUBJECTS HAVING HYPER-ENGORGED CIRCULATING CANCER ASSOCIATED MACROPHAGE-LIKE CELLS (CAMLS)
#111TGF- B receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#112NALCN Channel Protein and Modulators Thereof
#113METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR
#114EUKARYOTIC TRANSLATION INITIATION FACTORS (EIFS) AS NOVEL BIOMARKERS IN BLADDER CANCER
#115Serotonin transporter gene and treatment of opioid-related disorders
#116KIT AND METHOD FOR SCREENING OF ANTIBODY USING GPCR-EMBEDDED NANODISCS
#117NOVEL ANTI-HVEGFR2 ANTIBODIES
#118THERAPEUTIC ANTIBODIES
#119Chimeric ABC Transporters and Screening Methods
#120NOVEL USE
#121DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#122ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#123Targeted delivery system and methods of use therefor
#124MSP NANOPORES AND RELATED METHODS
#125METHODS FOR DELIVERING AN ANALYTE TO TRANSMEMBRANE PORES
#126CX3CR1-BINDING COMPOUNDS, METHODS AND USES THEREOF
#127MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#128PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#129SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#130CD91 POLYPEPTIDE FOR USE IN DETECTING HEMOPEXIN:HEME COMPLEX
#131MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#132HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47
#133ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE
#134SPATIAL SIGNALING NETWORKS FOR MULTIPLEXED DRUG RESPONSE MEASUREMENT AND MODELING
#135METHODS FOR MEASURING CRALBP ACTIVITY
#136METHODS OF SELECTIVELY TARGETING CD6 HIGH CELLS AND DECREASING ACTIVITY OF TEFF CELLS
#137Membrane and droplet-interface bilayer systems and methods
#138Time Dependent Response of Basophils to Allergens
#139THREE-DIMENTIONAL SURFACE FOR PROTEIN AND SMALL MOLECULE MICROARRAYS
#140Compositions And Methods Comprising D-Cysteine Or A D-Derivative Thereof
#141INCREASED VOLTAGE-GATED SODIUM CHANNEL ALPHA PROTEIN SUBUNIT EXPRESSION THROUGH VIRAL 2A-MEDIATED CO-EXPRESSION OF NAV BETA SUBUNITS
#142LABELS COMPRISING DIBROMOPYRIDAZINEDIONES FOR IMMUNOASSAYS AND METHODS OF PRODUCTION AND USE THEREOF
#143METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MODULATING TEMPERATURE AND PRODUCING ANALYTE IMAGING DATA
#144COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ITCH
#145METHODS FOR TREATING DRUG RESISTANT CANCERS
#146METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#147REGULATORS OF CELL DIVISION
#148BINDING SITE IN TYPE 1 RYANODINE RECEPTOR
#149METHODS OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA
#150HUMANIZED OR CHIMERIC CD3 ANTIBODIES
#151BINDING SITE IN TYPE 2 RYANODINE RECEPTOR
#152GPCR19-P2XN RECEPTOR COMPLEX AND USE THEREOF
#153METHODS FOR DELIVERING AN ANALYTE TO TRANSMEMBRANE PORES
#154METHODS FOR ISOLATING CENTRAL NERVOUS SYSTEM SURFACE MARKER DISPLAYING AGENTS
#155SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS
#156SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)
#157Systems and methods to identify and treat subjects at risk for obstetrical complications
#158IMMUNOASSAY ANALYZER, IMMUNOASSAY KIT AND METHOD FOR DETECTING ANALYTE IN LIQUID SAMPLE
#159MUTANT INSECT OLFACTORY RECEPTOR PROTEIN
#160BETA2-MICROGLOBULIN CONCENTRATION ANALYZING METHOD AND DEVICE
#161GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
#162Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome
#163NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE
#164METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#165METHODS FOR CLASSIFICATION AND TREATMENT OF PSYCHOTIC DISORDER SUBJECTS
#166RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG
#167Binding Members to PD-L1
#168COMPOSITIONS AND METHODS FOR TREATMENT
#169METHOD FOR JUDGING RISK OF SUFFERING KIDNEY CANCER
#170METHOD FOR RECOVERING EXTRACELLULAR VESICLE
#171Detection and quantification of AKT-mTOR pathway proteins
#172MAM-SPECIFIC FLUORESCENCE MARKER AND USE THEREOF
#173PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#174Analytical assay reaction cartridge containing magnetic capture beads and methods of production and use thereof
#175Use Of Biomarker Or Biomarkers Combinations In Preparing A Diagnostic Reagent For Fulminant Myocarditis And A Drug For Fulminant Myocarditis
#176IMMUNE STATUS BIOMARKERS AND USES THEREFOR
#177KINDLIN-1 AS A MARKER OF SENSITIVITY TO EGFR/RAS PATHWAY INHIBITORS
#178ANASTASIS BIOSENSOR
#179AFFINITY-MATURATED ANTI-ASIC1a ANTIBODIES
#180NOVEL ION CONDUCTING CHANNEL FUSION SUBUNITS AND METHODS OF USE THEREOF
#181Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient
#182ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR
#183DETECTION AND TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
#184ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY
#185Method for Measuring Modulation in the Activity of a G Protein-Coupled Receptor
#186COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX
#187ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
#188ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF
#189AFFINITY LIGAND FOR THE SOLUBLE PART OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 (sFGFR3)
#190ANALYTE DETECTION WITH REDOX ACTIVE POLYMER-COATED ELECTRODE
#191Apolipoprotein L1-Specific Antibodies and Methods of Use
#192ANTI-TLR7 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#193Methods for Identifying Modulators of G Protein-Coupled Receptors
#194ANTI-PD-L1 ANTIBODIES AND METHODS OF USING THE SAME FOR DETECTION OF PD-L1
#195ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#196METHOD FOR SCREENING PORE-FORMING MEMBRANE PROTEINS, MEMBRANE TRANSPORTERS AND MOLECULAR SWITCHES
#197METHOD FOR TREATING GASTRIC CANCER BY BLOCKING CCL28 CHEMOTACTIC PATHWAY
#198METHODS FOR INKJET PRINTING OBJECTS FOR MICROFLUIDIC DEVICES
#199COMPOSITIONS AND METHODS FOR DETECTING CELLS UNDERGOING FERROPTOSIS USING AN ANTIBODY
#200MAGNETIC ANALYSIS OF EXTRACELLULAR VESICLE GLYCANS
#201METHODS FOR SCREENING CEREBLON MODIFYING COMPOUNDS
#202Modulators of ATP-binding cassette transporters
#203METHOD FOR DIAGNOSING HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1)-RELATED DISEASE
#204THERAPY FOR DIABETES USING STEM CELL MIGRATION AGENT
#205ANTI-PSGL-1 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFALMMATORY PHENOTYPES AND USES THEREOF
#206MEANS AND METHODS FOR MULTIPARAMETER CYTOMETRY-BASED LEUKOCYTE SUBSETTING
#207Membrane and droplet-interface bilayer systems and methods
#208Olfactory receptor as microglia marker and use thereof
#209Cardiovascular Risk Event Prediction and Uses Thereof
#210LECTIN-MACROMOLECULE CARRIER COUPLING COMPLEX FOR SEPARATING GLYCOSYLATED EXOSOME IN CLINICAL SAMPLE
#211Device for collecting, preserving and storing eukaryotic cells contained in a sample of biological fluid for further cell analysis
#212XBP1 ISOFORM MULTIPLEX ASSAY
#213ASSAY FOR IMMUNE CELL RECOVERY
#214USE OF ENDOTHELIN RECEPTOR INHIBITOR FOR INHIBITING EXOSOME SECRETION OR INHIBITING PD-L1 EXPRESSION
#215BIOASSAY METHOD
#216Anti-T-cell nanobody and nucleic acid encoding sequence thereof, and uses of the same
#217Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof
#218METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF LUNG CANCER
#219IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#220ANTIBODIES THAT BIND TO LRP6 PROTEINS AND METHODS OF USE
#221METHOD FOR TREATING ALZHEIMER'S DISEASE BY INHIBITING UPTAKE OF AMINO ACIDS BY T CELLS
#222COMPOSITIONS AND METHODS FOR DETECTING HIV LATENCY, TREATING HIV INFECTION, AND REVERSING HIV LATENCY
#223Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#224High efficiency targeted in situ genome-wide profiling
#225BNIP3 PEPTIDES FOR TREATMENT OF REPERFUSION INJURY
#226High efficiency targeted in situ genome-wide profiling
#227MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#228INSULIN-LIKE GROWTH FACTOR AXIS PROTEINS AS CIRCULATING PULMONARY ARTERIAL HYPERTENSION BIOMARKERS
#229Bone marrow adipose portion isolation device and methods
#230COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#231Neuromodulation to target glucose transporter and/or incretin pathways
#232IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#233PORE
#234Glycated CD59 peptides, their preparation, and uses thereof
#235EPITOPES IN THE RNA RECOGNITION MOTIF 1 (RRM1) OF TDP-43 AND MISFOLDING-SELECTIVE ANTIBODIES THERETO
#236CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#237NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1
#238METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#239Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#240Lipocalin muteins with binding affinity for LAG-3
#241ANALYSIS OF POLYMORPHISMS IN SIRP-ALPHA FOR EVALUATING RESPONSE TO IMMUNOTHERAPY
#242NANOPORES WITH INTERNAL PROTEIN ADAPTORS
#243IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#244LYMPHANGIOGENESIS-PROMOTING AGENTS
#245AFFINITY-OLIGONUCLEOTIDE CONJUGATES AND USES THEREOF
#246X-aptamers for the use in detection of SNAP25
#247MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#248METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
#249Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof
#250SYSTEM AND METHOD FOR ANALYZING EXTRACELLULAR VESICLES WITH AN OPTICAL BIOSENSOR
#251MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY
#252USE OF LIGANDS DERIVED FROM RECEPTOR-BINDING DOMAIN OF PORCINE ENDOGENOUS RETROVIRUS TYPE B FOR DIAGNOSING SMVT-RELATED DISEASES
#253PD-L1 binding polypeptides for imaging
#254BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME
#255Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH
#256BT TOXIN RECEPTORS AND METHODS OF USE
#257METHOD FOR IDENTIFYING MODULATORS OF NOTCH SIGNALING
#258TGF- RECEPTOR II ISOFORM, FUSION PEPTIDE, METHODS OF TREATMENT AND METHODS IN VITRO
#259Method for screening saltiness enhancer using saltiness receptor
#260Use of regulatory T cell-specific surface protein LRIG-1
#261PROTEIN NANOPORE FOR IDENTIFYING AN ANALYTE
#262ANTIBODY TARGETING CTLA-4 , PREPARATION METHOD THEREFOR AND USE THEREOF
#263Sensors and assays for ubiquitin or ubiquitin-like proteins
#264METHODS FOR DETECTING DISORDERS RELATED TO CALCIUM DISCHARGE FROM INTRACELLULAR STORES
#265Serotonin transporter gene and treatment of opioid-related disorders
#266Nucleic acid linked immune-sandwich assay (NULISA)
#267Nucleic acid linked immune-sandwich assay (NULISA)
#268METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#269Biosensor Device and Methods
#270BIOSENSORS FOR DETECTING ARRESTIN SIGNALING
#271CELL POPULATIONS AND GENE EXPRESSION ASSOCIATED WITH IN VITRO BETA CELL DIFFERENTIATION
#272Humanized and chimeric monoclonal antibodies to CD47
#273Composition for immunostaining cleared large tissues and method for immunostaining cleared large biological tissues
#274METHODS FOR USE OF CDX2 AS A BIOMARKER TO GUIDE USE OF AUTOPHAGY INHIBITORS IN OVARIAN CANCER
#275ANTI-TLR9 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#276Neuropilin-1 Specific Binding Peptides and its Fusion Protein, and Use Thereof
#277MSP nanopores and related methods
#278Targeted delivery system and methods of use therefor
#279TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)
#280Anti-human LAG-3 monoclonal antibody and use thereof
#281Methods for delivering an analyte to transmembrane pores
#282METHODS AND COMPOSITIONS FOR DETERMINING THE POTENCY OF A THERAPEUTIC CELLULAR COMPOSITION
#283METHODS OF TREATING NEUROLOGICAL DISEASES AND DISORDERS
#284Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
#285TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#286PEPTIDES
#287Targeting NCchannel for organ protection following ischemic episode
#288PATIENT ASSESSMENT METHOD
#289Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents
#290Method for measuring membrane potential/membrane current of cell
#291Humanized and chimeric monoclonal antibodies to CD47
#292Methods for simultaneous measurement of multiple biological signals from spectrally identical fluorescent reporters
#293Anti-STAT3 specific antibody and the pharmaceutical composition comprising thereof
#294Method of treating or preventing neurodegeneration
#295Anti-hypusine antibodies and uses thereof
#296METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS
#297METHOD FOR MONITORING DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM
#298METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#299DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#300Eukaryotic translation initiation factors (eIFs) as novel biomarkers in bladder cancer